Wordt geladen...
Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types
PURPOSE: The efficacy and safety of regorafenib have been demonstrated in phase 3 trials for multiple tumor types, including metastatic colorectal cancer (mCRC) (CORRECT [NCT01103323]; CONCUR [NCT01584830]), advanced gastrointestinal stromal tumor (GIST) (GRID [NCT01271712]), and hepatocellular carc...
Bewaard in:
| Gepubliceerd in: | Cancer Manag Res |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8285228/ https://ncbi.nlm.nih.gov/pubmed/34285574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S305939 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|